International Society for the Study of Women's Sexual Health

Bulletin Board

May 1 Deadline to Submit NVA Research Grant Application

nva.jpg

NVA Invites Medical Research Proposals

Deadline to Submit Letter of Intent is Tuesday, March 21, 2017

Deadline to Submit Application is Monday, May 1, 2017

The NVA is seeking research proposals on the causes and treatment of vulvodynia. We are especially interested in studies that may shed light on underlying pathophysiological mechanisms.

If you are interested in applying, please send an email to Phyllis Mate (This email address is being protected from spambots. You need JavaScript enabled to view it.) by Tuesday, March 21, 2017 that includes a brief (1-2 paragraph) summary of your proposed study's design and objectives. Once we have received this information from you, we will email you a full application to complete and submit by Monday, May 1, 2017

The maximum grant amount is between $25,000 and $30,000 and we require confirmation that all funds will be applied to direct research costs, not institutional costs. If you've previously applied and/or received grant support from the NVA, you are still eligible to apply. Summaries of studies that NVA has funded to date can be viewed on NVA's web site.

We welcome correspondence about potential projects. To discuss your proposal, please contact Phyllis Mate via email (This email address is being protected from spambots. You need JavaScript enabled to view it.).

Contact NVA

National Vulvodynia Association
PO Box 4491
Silver Spring, MD 20914-4491

Phone: 301-949-5114
Fax: 301-299-3999
Website: www.nva.org

Category: Grants / Awards

Save the Date

ISSWSH Fall Course 2018
November 15-17, 2018   116 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH / ISSM Joint Meeting 2019
March 7-10, 2019   228 days left
Atlanta, GA, USA

Latest Tweets

Pelvic exam is essential to the accurate diagnosis and treatment of #FSD, but it has a complicated history https://t.co/YTOy3eSbtJ ISSWSH
Check out these great books focusing on women's sexuality and #sexualhealth @ISSWSH https://t.co/gh0S07A5uk ISSWSH
#Addyi ( #flibanserin), the first FDA-approved treatment for hypoactive sexual desire disorder for premenopausal wom… https://t.co/IKuST5SqZZ ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.